Clinical Trial Update: Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis [Phase 2]

View source ↗

Summary

A Phase 2 trial of an immunomodulatory therapy for adults with perennial allergic rhinitis and rhinoconjunctivitis due to house dust mite and/or cat has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Perennial Allergic Rhinitis

Drugs mentioned

• Immunomodulatory Therapy

Snippet

Sponsor: Cytos Biotechnology AG | Conditions: Perennial Allergy to House Dust Mite and/or Cat | Phase 2 | Status: COMPLETED